Legend Biotech Gets FDA Clearance for Small Cell Lung Cancer Trial .

 

Nov. 21, 2022 at 9:17 a.m. ET

By Sabela Ojea

Legend Biotech Corp. said Monday the U.S. Food and Drug Administration cleared its investigational new drug application for the treatment of small cell lung cancer.

The company, engaged in the discovery and development of novel cell therapies for oncology and other indications, said the Phase 1 trial for its LB2102 drug is designed to evaluate the safety and preliminary efficacy of the treatment while seeking to determine the recommended dose for a Phase 2 trial . ...